← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

DCGO logoDocGo Inc.(DCGO)Earnings, Financials & Key Ratios

DCGO•NASDAQ
$0.63
$63M mkt cap·Price updated May 7, 2026
SectorHealthcareIndustryHealthcare FacilitiesSub-IndustryHome-based care services
AboutDocGo, Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home and offices; COVID-19 testing; and event services, which include on-site healthcare support at sporting events and concerts. DocGo, Inc. was incorporated in 2015 and is headquartered in New York, New York.Show more
  • Revenue$322196B+52257351.6%
  • EBITDA-$162371.64B-364277491.9%
  • Net Income-$182399.63B-912356659.3%
  • EPS (Diluted)-1.84-1122.2%
  • Gross Margin30.65%-11.5%
  • EBITDA Margin-50.4%-797.1%
  • Operating Margin-55.26%-1287.5%
  • Net Margin-56.61%-1845.9%
  • ROE-289.82%-4596.5%
  • ROIC-260.37%-3582.1%
  • Debt/Equity0.23+27.8%
Technical→

DCGO Key Insights

DocGo Inc. (DCGO) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Strong 5Y sales CAGR of 1927.3%
  • ✓Share count reduced 9.5% through buybacks
  • ✓Efficient asset utilization: 1.5x turnover

✗Weaknesses

  • ✗Weak momentum: RS Rating 13 (bottom 13%)
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

DCGO Price & Volume

DocGo Inc. (DCGO) stock price & volume — 10-year historical chart

Loading chart...

DCGO Growth Metrics

DocGo Inc. (DCGO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years1927.28%
3 Years8909.89%
TTM52257351.65%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-99999900%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-1122.97%

Return on Capital

10 Years-35.33%
5 Years-41.39%
3 Years-74.77%
Last Year-237.99%

DCGO Peer Comparison

DocGo Inc. (DCGO) competitors in Home-based care services — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
OPRX logoOPRXOptimizeRx CorporationDirect Competitor123.59M6.6324.5618.78%4.69%4.22%0.04
TALK logoTALKTalkspace, Inc.Direct Competitor867.72M5.18129.5022%3.4%6.89%
HIMS logoHIMSHims & Hers Health, Inc.Direct Competitor6.63B25.6750.3259%5.47%23.73%2.07
DOCS logoDOCSDoximity, Inc.Direct Competitor5.24B26.0323.4519.98%37.54%24.45%0.01
AMR logoAMRAlpha Metallurgical Resources, Inc.Product Competitor2.52B193.4313.55-14.81%-1.73%-2.38%0.00
EVGO logoEVGOEVgo, Inc.Product Competitor595.8M1.90-6.1349.55%-11.15%-12.2%0.28
AMSF logoAMSFAMERISAFE, Inc.Product Competitor569.48M30.3012.272.63%14.27%9.68%0.00
ALHC logoALHCAlignment Healthcare, Inc.Product Competitor3.73B18.25-4932.4346.06%0.47%11.5%1.89

Compare DCGO vs Peers

DocGo Inc. (DCGO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs OPRX

Most directly comparable listed peer for DCGO.

Scale Benchmark

vs AMZN

Larger-name benchmark to compare DCGO against a more recognizable public peer.

Peer Set

Compare Top 5

vs OPRX, TALK, HIMS, DOCS

DCGO Income Statement

DocGo Inc. (DCGO) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue48.3M94.09M318.72M440.52M624.29M616.56M322.2T
Revenue Growth %-94.81%238.74%38.21%41.72%-1.24%52257351.65%
Cost of Goods Sold35.11M62.74M208.97M285.79M428.91M402.98M223.44T
COGS % of Revenue72.69%66.68%65.57%64.88%68.7%65.36%69.35%
Gross Profit
13.19M▲ 0%
31.35M▲ 137.7%
109.75M▲ 250.1%
154.72M▲ 41.0%
195.38M▲ 26.3%
213.57M▲ 9.3%
98.76T▲ 46240281.8%
Gross Margin %27.31%33.32%34.43%35.12%31.3%34.64%30.65%
Gross Profit Growth %-137.67%250.1%40.98%26.28%9.31%46240281.84%
Operating Expenses33.95M46.1M94.39M132.89M180.33M184.89M148.43T
OpEx % of Revenue70.3%49%29.62%30.17%28.89%29.99%46.07%
Selling, General & Admin28.55M39.41M83.56M116.94M153.04M157.41M134.87T
SG&A % of Revenue59.11%41.88%26.22%26.55%24.51%25.53%41.86%
Research & Development1.22M1.19M3.32M5.38M10.86M11.59M13.56T
R&D % of Revenue2.53%1.26%1.04%1.22%1.74%1.88%4.21%
Other Operating Expenses4.18M5.51M7.51M10.57M16.43M15.88M0
Operating Income
-20.76M▲ 0%
-14.76M▲ 28.9%
15.36M▲ 204.1%
21.83M▲ 42.2%
15.05M▼ 31.0%
28.69M▲ 90.6%
-178.03T▼ 620569657.5%
Operating Margin %-42.99%-15.68%4.82%4.96%2.41%4.65%-55.26%
Operating Income Growth %-28.92%204.06%42.16%-31.04%90.56%-99999900%
EBITDA-16.58M-9.25M22.87M32.4M31.49M44.57M-162.37T
EBITDA Margin %-34.33%-9.83%7.18%7.35%5.04%7.23%-50.4%
EBITDA Growth %-44.21%347.23%41.66%-2.81%41.56%-99999900%
D&A (Non-Cash Add-back)4.18M5.51M7.51M10.57M16.43M15.88M15.66T
EBIT-20.76M-14.76M20.56M21.83M15.05M29.68M0
Net Interest Income-545.87K-204.63K-763.03K762.68K1.68M-1.93M0
Interest Income545.87K00762.68K1.68M236.95K0
Interest Expense0204.63K763.03K002.17M-1.24T
Other Income/Expense-428.28K125.91K4.44M950.26K1.24M-939.72K-9.47T
Pretax Income
-21.19M▲ 0%
-14.63M▲ 31.0%
19.8M▲ 235.3%
22.78M▲ 15.1%
16.29M▼ 28.5%
27.75M▲ 70.3%
-187.5T▼ 675696481.9%
Pretax Margin %-43.87%-15.55%6.21%5.17%2.61%4.5%-58.19%
Income Tax47.03K167.44K615.7K-7.96M6.24M14.39M-8.87T
Effective Tax Rate %-0.22%-1.14%3.11%-34.95%38.33%51.85%4.73%
Net Income
-20.21M▲ 0%
-14.36M▲ 28.9%
23.74M▲ 265.3%
34.58M▲ 45.7%
6.86M▼ 80.2%
19.99M▲ 191.5%
-182.4T▼ 912356659.3%
Net Margin %-41.84%-15.26%7.45%7.85%1.1%3.24%-56.61%
Net Income Growth %-28.95%265.35%45.66%-80.17%191.5%-99999900%
Net Income (Continuing)-21.24M-14.8M19.18M30.74M10.05M13.36M-182.4T
Discontinued Operations0000000
Minority Interest10.89M11.95M7.48M5.7M4.38M-5.74M-18.14T
EPS (Diluted)
-0.20▲ 0%
-0.14▲ 30.0%
0.25▲ 278.6%
0.34▲ 36.0%
0.06▼ 80.9%
0.18▲ 177.3%
-1.84▼ 1122.2%
EPS Growth %-30%278.57%36%-80.91%177.35%-1122.22%
EPS (Basic)-0.20-0.140.300.340.070.20-1.84
Diluted Shares Outstanding100.22M100.22M94.86M102.98M105.62M109.42M99.07M
Basic Shares Outstanding100.22M100.22M80.29M101.23M103.51M102.4M99.07M
Dividend Payout Ratio-----6474653.57%-

DCGO Balance Sheet

DocGo Inc. (DCGO) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets59.14M58.42M256.03M271.08M338.87M304.49M152.4T
Cash & Short-Term Investments47.74M32.42M175.54M157.34M59.29M89.24M52.48T
Cash Only47.74M32.42M175.54M157.34M59.29M89.24M52.48T
Short-Term Investments0000000
Accounts Receivable10.16M24.85M78.38M103M262.08M210.9M92.89T
Days Sales Outstanding76.896.4289.7785.34153.23124.85105.23
Inventory0004.48M000
Days Inventory Outstanding---5.72---
Other Current Assets0106.27M17.5M4.34M7.02T
Total Non-Current Assets41.82M41.75M53.57M122.2M151.58M151.13M64.7T
Property, Plant & Equipment20.41M21.1M26.24M39.37M38.42M42.18M43.5T
Fixed Asset Turnover2.37x4.46x12.15x11.19x16.25x14.62x7.41x
Goodwill6.31M6.61M8.69M38.9M47.54M47.43M0
Intangible Assets9.97M10.67M10.68M22.97M37.68M25.73M0
Long-Term Investments00589.06K597.98K553.57K5.55M0
Other Non-Current Assets5.13M3.36M7.38M10.4M15.5M21.83M20.67T
Total Assets
100.96M▲ 0%
100.17M▼ 0.8%
309.6M▲ 209.1%
393.28M▲ 27.0%
490.45M▲ 24.7%
455.62M▼ 7.1%
217.1T▲ 47649799.6%
Asset Turnover0.48x0.94x1.03x1.12x1.27x1.35x1.48x
Asset Growth %--0.78%209.07%27.03%24.71%-7.1%47649799.61%
Total Current Liabilities9.73M23.5M57.88M100.16M170.12M121.81M67.49T
Accounts Payable947.94K3.95M15.83M21.58M19.83M28.36M11.11T
Days Payables Outstanding9.852327.6627.5616.8725.6818.15
Short-Term Debt564.91K664.36K626.33K664.91K25.03M30.01M10.21T
Deferred Revenue (Current)0000000
Other Current Liabilities680.49K3.58M11.89M49.38M39.81M27.4M57.28T
Current Ratio6.08x2.49x4.42x2.71x1.99x2.50x2.26x
Quick Ratio6.08x2.49x4.42x2.66x1.99x2.50x2.26x
Cash Conversion Cycle---63.5---
Total Non-Current Liabilities11.87M9.73M24.67M14.19M15.16M18.64M23.74T
Long-Term Debt751.5K594.49K1.3M1.24M41.59K5.21K18.97T
Capital Lease Obligations11.12M9.14M9.85M12.96M15.12M18.63M0
Deferred Tax Liabilities0000000
Other Non-Current Liabilities0013.52M0004.78T
Total Liabilities21.6M33.23M82.55M114.35M185.28M140.44M91.23T
Total Debt15.54M13.89M16.51M19.91M46.5M57.19M29.18T
Net Debt-32.2M-18.53M-159.03M-137.42M-12.79M-32.05M-23.31T
Debt / Equity0.20x0.21x0.07x0.07x0.15x0.18x0.23x
Debt / EBITDA--0.72x0.61x1.48x1.28x-
Net Debt / EBITDA---6.95x-4.24x-0.41x-0.72x-
Interest Coverage--72.12x20.13x--13.24x-
Total Equity
79.36M▲ 0%
66.95M▼ 15.6%
227.06M▲ 239.2%
278.93M▲ 22.8%
305.17M▲ 9.4%
315.18M▲ 3.3%
125.87T▲ 39936344.1%
Equity Growth %--15.64%239.16%22.84%9.41%3.28%39936344.08%
Book Value per Share0.790.672.392.712.892.88999999.00
Total Shareholders' Equity68.47M55M219.58M273.23M300.79M320.92M144.01T
Common Stock0010.01K10.24K10.41K10.19K9.86B
Retained Earnings-72.94M-87.3M-63.56M-28.97M-21.39M-1.4M-183.8T
Treasury Stock0000000
Accumulated OCI-244.88K-48.54K-32.5K741.21K1.48M1.22M2.39T
Minority Interest10.89M11.95M7.48M5.7M4.38M-5.74M-18.14T

DCGO Cash Flow Statement

DocGo Inc. (DCGO) cash flow — operating, investing & free cash flow history

Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations-14.21M-10.65M-1.95M28.87M-64.22M70.34M34.45T
Operating CF Margin %-29.41%-11.32%-0.61%6.55%-10.29%11.41%10.69%
Operating CF Growth %-25%81.72%1582.47%-322.45%209.52%48980692.06%
Net Income-21.24M-14.8M19.18M30.74M6.86M19.99M-196.37T
Depreciation & Amortization4.18M5.51M7.07M10.57M16.43M15.88M10.45T
Stock-Based Compensation457.47K687.07K1.38M8.05M20.97M13.63M17.44T
Deferred Taxes2.47M1.85M-630.38K-9.96M-1.98M3.47M7.75T
Other Non-Cash Items147.51K-300K-142.67K2.64M6.62M-2.16M195.19T
Working Capital Changes-224.22K-3.61M-28.8M-13.18M-113.12M19.52M0
Change in Receivables-2.28M-16.15M-58M-8.42M-160.52M41.27M112.5T
Change in Inventory0000000
Change in Payables-100.67K3.01M11.88M3.64M-1.78M8.56M-17.64T
Cash from Investing-2.97M-6.04M-8.59M-38.45M-29.88M-10.87M-39.08T
Capital Expenditures-1.45M-4.36M-4.81M-3.2M-7.58M-3.83M-4.54T
CapEx % of Revenue3%4.64%1.51%0.73%1.21%0.62%1.41%
Acquisitions-335.48K1.78M-1.96M-32.95M-19.46M-310.45K-16.39T
Investments-------
Other Investing-1.19M-3.45M-1.82M-2.3M-2.84M-1.73M-2.69T
Cash from Financing56.34M-812.09K155.21M-6.18M1.12M-24.15M-50.82T
Debt Issued (Net)-3.2M-2.28M-2.82M-3.94M20.7M613.55K0
Equity Issued (Net)1000K01000K-1000K1000K-1000K0
Dividends Paid00000-1.29T0
Share Repurchases00-479.33K-3.73M0-13.76M0
Other Financing10.5M1.47M-19.6M1.49M-21.17M1.29T-50.82T
Net Change in Cash
38.91M▲ 0%
-17.31M▼ 144.5%
144.65M▲ 935.6%
-15M▼ 110.4%
-91.89M▼ 512.7%
35.12M▲ 138.2%
-54.85T▼ 156189136.2%
Free Cash Flow
-18.01M▲ 0%
-16.97M▲ 5.8%
-8.6M▲ 49.3%
23.37M▲ 371.6%
-74.35M▼ 418.1%
64.5M▲ 186.8%
29.91T▲ 46367582.7%
FCF Margin %-37.29%-18.04%-2.7%5.31%-11.91%10.46%9.28%
FCF Growth %-5.76%49.3%371.61%-418.11%186.76%46367582.67%
FCF per Share-0.18-0.17-0.090.23-0.700.59301885.92
FCF Conversion (FCF/Net Income)0.70x0.74x-0.08x0.83x-9.36x3.52x-0.19x
Interest Paid1.07M1.05M840.75K756.6K850.34K2.91M0
Taxes Paid47.03K117.44K615.7K1.51M4.25M7.25M0

DCGO Key Ratios

DocGo Inc. (DCGO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric2019202020212022202320242025
Return on Equity (ROE)-25.47%-19.63%16.15%13.67%2.35%6.45%-289.82%
Return on Invested Capital (ROIC)-33.02%-23.16%19.78%15.63%5.2%7.48%-260.37%
Gross Margin27.31%33.32%34.43%35.12%31.3%34.64%30.65%
Net Margin-41.84%-15.26%7.45%7.85%1.1%3.24%-56.61%
Debt / Equity0.20x0.21x0.07x0.07x0.15x0.18x0.23x
Interest Coverage--72.12x20.13x--13.24x-
FCF Conversion0.70x0.74x-0.08x0.83x-9.36x3.52x-0.19x
Revenue Growth-94.81%238.74%38.21%41.72%-1.24%52257351.65%

DCGO Frequently Asked Questions

DocGo Inc. (DCGO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

DocGo Inc. (DCGO) reported $329.7M in revenue for fiscal year 2025. This represents a 583% increase from $48.3M in 2019.

DocGo Inc. (DCGO) grew revenue by 52257351.6% over the past year. This is strong growth.

DocGo Inc. (DCGO) reported a net loss of $182.40T for fiscal year 2025.

Dividend & Returns

DocGo Inc. (DCGO) has a return on equity (ROE) of -289.8%. Negative ROE indicates the company is unprofitable.

DocGo Inc. (DCGO) generated $19.47T in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

Explore More DCGO

DocGo Inc. (DCGO) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.